blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2332964

EP2332964 - APOPTOTICALLY ACTIVE PEPTIDES [Right-click to bookmark this link]
Former [2011/24]Apoptotically active peptides
[2015/48]
StatusNo opposition filed within time limit
Status updated on  24.02.2017
Database last updated on 15.07.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG		published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
CytoTools AG
Klappacher Strasse 126
64285 Darmstadt / DE
[2011/24]
Inventor(s)01 / Freyberg, Mark
Klappacher Strasse 126
64285 Darmstadt / DE
02 / Kaiser, Dirk
Odenwaldring 61
64859 Eppertshausen / DE
03 / Friedl, Peter
Am Köpfchen 11
64823 Groß-Umstadt / DE
 [2011/24]
Representative(s)Schultheiss, Jürgen
Hauptstraße 17-19
Gebäude 6301A
55120 Mainz / DE
[2016/16]
Former [2011/24]Schultheiss, Jürgen
Hauptstraße 17-19 Gebäude 6301A
55120 Mainz / DE
Application number, filing date10010931.318.12.2002
[2011/24]
Priority number, dateDE200116313020.12.2001         Original published format: DE 10163130
[2011/24]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP2332964
Date:15.06.2011
Language:DE
[2011/24]
Type: B1 Patent specification 
No.:EP2332964
Date:20.04.2016
Language:DE
[2016/16]
Search report(s)(Supplementary) European search report - dispatched on:EP19.04.2011
ClassificationIPC:C07K7/06, A61K38/08
[2011/24]
CPC:
C07K14/4747 (EP,US); A61P17/02 (EP); A61P25/28 (EP);
A61P31/18 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P9/10 (EP); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2016/16]
Former [2011/24]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  SI,  SK,  TR 
TitleGerman:Apoptotisch wirksame Peptide[2011/24]
English:APOPTOTICALLY ACTIVE PEPTIDES[2015/48]
French:PEPTIDES AYANT UN EFFET SUR L'APOPTOSE[2015/48]
Former [2011/24]Apoptotically active peptides
Former [2011/24]Peptides ayant un effet sur l'apoptose
Examination procedure09.12.2011Amendment by applicant (claims and/or description)
09.12.2011Examination requested  [2012/03]
09.07.2015Despatch of a communication from the examining division (Time limit: M04)
31.08.2015Reply to a communication from the examining division
13.11.2015Communication of intention to grant the patent
03.03.2016Fee for grant paid
03.03.2016Fee for publishing/printing paid
03.03.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP02805332.0  / EP1458748
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20020805332) is  22.09.2006
Opposition(s)23.01.2017No opposition filed within time limit [2017/13]
Fees paidRenewal fee
27.09.2010Renewal fee patent year 03
27.09.2010Renewal fee patent year 04
27.09.2010Renewal fee patent year 05
27.09.2010Renewal fee patent year 06
27.09.2010Renewal fee patent year 07
27.09.2010Renewal fee patent year 08
23.12.2010Renewal fee patent year 09
14.12.2011Renewal fee patent year 10
20.12.2012Renewal fee patent year 11
17.12.2013Renewal fee patent year 12
29.12.2014Renewal fee patent year 13
17.12.2015Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBG20.04.2016
CY20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
FI20.04.2016
IT20.04.2016
MC20.04.2016
NL20.04.2016
SI20.04.2016
SK20.04.2016
TR20.04.2016
GR21.07.2016
PT22.08.2016
LU18.12.2016
[2018/38]
Former [2018/29]CY20.04.2016
CZ20.04.2016
DK20.04.2016
EE20.04.2016
FI20.04.2016
IT20.04.2016
MC20.04.2016
NL20.04.2016
SI20.04.2016
SK20.04.2016
TR20.04.2016
GR21.07.2016
PT22.08.2016
LU18.12.2016
Former [2017/49]CZ20.04.2016
DK20.04.2016
EE20.04.2016
FI20.04.2016
IT20.04.2016
MC20.04.2016
NL20.04.2016
SI20.04.2016
SK20.04.2016
GR21.07.2016
PT22.08.2016
LU18.12.2016
Former [2017/47]CZ20.04.2016
DK20.04.2016
EE20.04.2016
FI20.04.2016
IT20.04.2016
MC20.04.2016
NL20.04.2016
SI20.04.2016
SK20.04.2016
GR21.07.2016
PT22.08.2016
Former [2017/37]CZ20.04.2016
DK20.04.2016
EE20.04.2016
FI20.04.2016
IT20.04.2016
NL20.04.2016
SI20.04.2016
SK20.04.2016
GR21.07.2016
PT22.08.2016
Former [2017/10]CZ20.04.2016
DK20.04.2016
EE20.04.2016
FI20.04.2016
IT20.04.2016
NL20.04.2016
SK20.04.2016
GR21.07.2016
PT22.08.2016
Former [2017/09]CZ20.04.2016
DK20.04.2016
EE20.04.2016
FI20.04.2016
IT20.04.2016
NL20.04.2016
GR21.07.2016
PT22.08.2016
Former [2017/07]DK20.04.2016
FI20.04.2016
IT20.04.2016
NL20.04.2016
GR21.07.2016
PT22.08.2016
Former [2017/04]FI20.04.2016
IT20.04.2016
NL20.04.2016
GR21.07.2016
PT22.08.2016
Former [2016/51]FI20.04.2016
NL20.04.2016
GR21.07.2016
PT22.08.2016
Former [2016/49]FI20.04.2016
NL20.04.2016
Documents cited:Search[A]US5399667  (FRAZIER WILLIAM A [US], et al) [A] 1-14;
 [A]WO9611942  (UNIV NEWCASTLE RES ASS [AU], et al) [A] 1-14;
 [A]WO9617059  (UNIV WASHINGTON [US], et al) [A] 1-14;
 [X]WO0045856  (IMARX PHARMACEUTICAL CORP [US]) [X] 1,4,5,9-14 * page 70, line 26 - page 71, line 10 *;
 [XI]WO0047102  (GEN HOSPITAL CORP [US], et al) [X] 1,9-11 * SEQ ID No. 6; page 84, line 16 - page 86, line 10 * * page 93, line 4 - page 95, line 26 * * page 102, line 25 - page 103, line 14 * * page 104, line 16 - page 106, line 20 * * page 107, line 26 - page 111, line 2 * [I] 12-14;
 [XI]  - SKEIKY Y. A. W. ET AL., "Streptomyces lividans ebrC repressor (ebrS) and multidrug resistance efflux protein (ebrC) genes, complete cds", EMBL, (20011101), Database accession no. AAU58153, XP002248159 [X] 1-3,7-9,11-13 * die Sequenz * [I] 4,5
 [XI]  - READ T. ET AL., "Bacillus anthracis str. Ames section 1 of 18 of the complete genome", GENBANK, Database accession no. ae017024, XP002248152 [X] 1-3,7 * die Sequenz des AAP24275 Polypeptids * [I] 12,13
 [XI]  - TETTELIN H. ET AL., "Neisseria meningitidis serogroup B strain MC58 section 157 of 206 of the complete genome", GENBANK, (20000525), Database accession no. AE002515, XP002248153 [X] 1-3,7 * die Sequenz des AAF41999 Polypeptids * [I] 12,13
 [XI]  - TETTELIN H. ET AL., "Neisseria meningitidis serogroup B strain MC58 section 36 to 206 of the complete genome", GENBANK, (20000525), Database accession no. AE002394, XP002248157 [X] 1-3,7 * die Sequenz des AAF40822 Polypeptids * [I] 12,13
 [XI]  - LEE L. F. ET AL., "Streptomyces lividans ebrC repressor (ebrS) and multidrug resistance efflux protein (ebrC) genes, complete cds", GENBANK, (20011103), Database accession no. AY043331, XP002248158 [X] 1-3,7 * die Sequenz des AAK95487 Polypeptids * [I] 12,13
 [X]  - DUBOIS E. ET AL., "S. cerevisiae chomosome II reading frame ORF YBR222c", GENBANK, (19980311), Database accession no. Z36091, XP002248154 [X] 1-3,7 * die Sequenz *
 [XI]  - FLEISCHMANN R. D. ET AL., "Haemophilus influenzae Rd section 148 of 163 of the complete genome", GENBANK, (19980529), Database accession no. U32833, XP002248148 [X] 1 * die Sequenz des AAC23241 Polypeptids * [I] 12,13
 [XI]  - FRIEDBERG D. ET AL., "Salmonella typhimurium leucine-responsive regulatory protein (Lrp) gene, complete cds", GENBANK, (19950919), Database accession no. U02273, XP002248149 [X] 1 * die Sequenz * [I] 12,13
 [XI]  - NAKAJIMA M. ET AL., "Pseudomonas syringae plasmid pPaCu1 ORFA, ORFB, ORFC, ORFD genes, complete cds", GENBANK, (20000603), Database accession no. AB033419, XP002248156 [X] 1 * die Sequenz des BAA85307 Polypeptids * [I] 12,13
 [X]  - STAPLETON M. ET AL., "Drosophila melanogaster LD41918 full length cDNA", GENBANK, (20011217), Database accession no. AY069650, XP002248151 [X] 1 * die Sequenz *
 [X]  - HARTMANN E. & GOERLICH D., "Drosophila melanogaster Ran binding protein 11 (Ranbp11) mRNA, complete cds", GENBANK, (20000601), Database accession no. AF245515, XP002248150 [X] 1 * die Sequenz *
 [X]  - LEE Y. A. ET AL., "Xanthomonas campestris juglandis copper-resistance genes, complete cds", GENBANK, (19940317), Database accession no. L19222, XP002248155 [X] 1 * die Sequenz des AAA72013 Polypeptids *
 [A]  - CARRON J A ET AL, "A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (20000421), vol. 270, no. 3, ISSN 0006-291X, pages 1124 - 1127, XP002248144 [A] 1-14

DOI:   http://dx.doi.org/10.1006/bbrc.2000.2574
 [A]  - GAO AI-GUO ET AL, "Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin.", JOURNAL OF BIOLOGICAL CHEMISTRY, (1996), vol. 271, no. 1, ISSN 0021-9258, pages 21 - 24, XP002248145 [A] 1-14

DOI:   http://dx.doi.org/10.1074/jbc.271.1.21
 [A]  - GAO A-G ET AL, "THROMBOSPONDIN MODULATES ALPHAVBETA3 FUNCTION THROUGH INTEGRIN-ASSOCIATED PROTEIN", THE JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, US, (199610), vol. 135, no. 2, ISSN 0021-9525, pages 533 - 544, XP000990435 [A] 1-14

DOI:   http://dx.doi.org/10.1083/jcb.135.2.533
 [A]  - KOSFELD MINH D ET AL, "Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin.", JOURNAL OF BIOLOGICAL CHEMISTRY, (1993), vol. 268, no. 12, ISSN 0021-9258, pages 8808 - 8814, XP002248146 [A] 1-14
 [A]  - JIMENEZ BENILDE ET AL, "Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1.", NATURE MEDICINE., (200001), vol. 6, no. 1, ISSN 1078-8956, pages 41 - 48, XP002248147 [A] 1-14

DOI:   http://dx.doi.org/10.1038/71517
ExaminationWO9858541
 WO9954464
by applicantUS4479930
 US4652440
 US4668503
    - FREYBERG ET AL., BBRC, (2001), vol. 286, pages 141 - 149
    - A. ADANG, RECL. TRAV. CHIM. PAYS-BAS, (1994), vol. 113, pages 63 - 78
    - J. GANTE, ANGEW. CHEM., (1994), vol. 106, pages 1780 - 1802
    - BORCHARD, JOURNAL OF CONTROLLED RELEASE, (1999), vol. 62, pages 231 - 238
    - BLACKWELL ET AL., J. ORG. CHEM., (2001), vol. 10, pages 5291 - 5302
    - COHEN ET AL., IMMUNOLOGY TODAY, (1993), vol. 14, no. 3, pages 126 - 130
    - DARZYNKLEWICZ Z. ET AL., CYTOMETRY, (1992), vol. 13, pages 795 - 808
    - ZAMAI L. ET AL., CYTOMETRY, (1993), vol. 14, pages 891 - 897
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.